CLINICAL INVESTIGATIONS

Short-, medium-, and long-term follow-up after percutaneous transluminal coronary angioplasty for stable and unstable angina pectoris The first 840 consecutive patients who underwent percutaneous transluminal coronary angioplasty (PTCA) performed in the same institution were retrospectively assessed at an average follow-up period of 25 months after the initial procedure. The study population consisted of 506 patients with stable angina pectoris (group 1) and 334 patients with unstable angina pectoris (group 2). Clinical end points were death, nonfatal myocardial infarction, recurrent angina pectoris necessitating bypass surgery or repeat PTCA, and event-free survival. The two groups were comparable with respect to age, sex, previous myocardial infarction, ejection fraction, and number of diseased vessels. PTCA was successful in 83.0 % of group 1 and 87.1% of group 2. Follow-up rates were expressed as events per attempted PTCA in a patient group. No difference in survival was observed between the two groups, the mortality rate being approximately 2.8 % at 25 months. In the group with stable angina pectorls there was a lower incidence of nonfatal myocardial infarction within the first 24 hours after angioplasty; 4.3 % vs 9.0 % (p < 0.01). During long-term follow-up the increase in the incidence of nonfatal myocardial infarction was similar, resulting in an overall long-term follow-up infarction rate of 8.3 % and 14.2%, respectively (p < 0.01). A higher event-free survival was observed in group 1 within 24 hours after PTCA: 93.7 % vs 84.2 % (p < 0.01). During subsequent follow-up the difference in event-free survival between the two groups was no longer significant: 68.5 % vs 61.2%. These results suggest that PTCA is an effective long-term treatment for both patients with stable and unstable angina pectoris but with an initially higher major complication rate in the latter patien